Email updates

Keep up to date with the latest news and content from BMC Pulmonary Medicine and BioMed Central.

Open Access Research article

Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis

Holger Dressel1*, Laura Filser1, Rainald Fischer2, Katharina Marten3, Ullrich Müller-Lisse4, Dorothea de la Motte1, Dennis Nowak1, Rudolf M Huber2 and Rudolf A Jörres1

Author Affiliations

1 Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwig-Maximilians-University, Ziemssenstr. 1, D-80336 München, Germany

2 Department of Pneumology, Medizinische Klinik Innenstadt, Ludwig-Maximilians-University, Munich, Germany

3 Department of Diagnostic Radiology, University of Göttingen, Göttingen, Germany

4 Institute for Clinical Radiology, Medizinische Klinik Innenstadt, Ludwig-Maximilians-University, Munich, Germany

For all author emails, please log on.

BMC Pulmonary Medicine 2009, 9:30  doi:10.1186/1471-2466-9-30

Published: 16 June 2009

Abstract

Background

Due to large-scale destruction, changes in membrane diffusion (Dm) may occur in cystic fibrosis (CF), in correspondence to alterations observed by computed tomography (CT). Dm can be easily quantified via the diffusing capacity for nitric oxide (DLNO), as opposed to the conventional diffusing capacity for carbon monoxide (DLCO). We thus studied the relationship between DLNO as well as DLCO and a CF-specific CT score in patients with stable CF.

Methods

Simultaneous single-breath determinations of DLNO and DLCO were performed in 21 CF patients (mean ± SD age 35 ± 9 y, FEV1 66 ± 28%pred). Patients also underwent spirometry and bodyplethysmography. CT scans were evaluated via the Brody score and rank correlations (rS) with z-scores of functional measures were computed.

Results

CT scores correlated best with DLNO (rS = -0.83; p < 0.001). Scores were also related to the volume-specific NO transfer coefficient (KNO; rS = -0.63; p < 0.01) and to DLCO (rS = -0.79; p < 0.001) but not KCO. Z-scores for DLNO were significantly lower than for DLCO (p < 0.001). Correlations with spirometric (e.g., FEV1, IVC) or bodyplethysmographic (e.g., SRaw, RV/TLC) indices were weaker than for DLNO or DLCO but most of them were also significant (p < 0.05 each).

Conclusion

In this cross sectional study in patients with CF, DLNO and DLCO reflected CT-morphological alterations of the lung better than other measures. Thus the combined diffusing capacity for NO and CO may play a future role for the non-invasive, functional assessment of structural alterations of the lung in CF.